X4 Pharmaceuticals Inc (XFOR) — Working Capital to Net Assets Ratio
X4 Pharmaceuticals Inc (XFOR) has a Working Capital to Net Assets ratio of 128.3% as of June 2026. Working capital of $199.49 Million (current assets of $218.85 Million minus current liabilities of $19.37 Million) is measured against net assets of $155.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see balance sheet size of X4 Pharmaceuticals Inc.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
X4 Pharmaceuticals Inc Working Capital to Net Assets (2015–2025)
This chart shows how X4 Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 128.3%, reflecting working capital of $199.49 Million against net assets of $155.45 Million USD. Check X4 Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Annual Working Capital to Net Assets for X4 Pharmaceuticals Inc (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for X4 Pharmaceuticals Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read XFOR total debt and obligations for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 126.6% | $235.82 Million | $186.29 Million | $261.58 Million | $25.76 Million | ▼ -231.4 pp |
| 2024 | 358.0% | $79.30 Million | $22.15 Million | $112.17 Million | $32.88 Million | ▲ +163.9 pp |
| 2023 | 194.2% | $99.21 Million | $51.10 Million | $122.08 Million | $22.86 Million | ▲ +50.5 pp |
| 2022 | 143.6% | $106.35 Million | $74.05 Million | $128.68 Million | $22.32 Million | ▲ +29.0 pp |
| 2021 | 114.7% | $73.86 Million | $64.41 Million | $87.88 Million | $14.02 Million | ▲ +16.6 pp |
| 2020 | 98.0% | $71.36 Million | $72.80 Million | $83.31 Million | $11.95 Million | ▲ +5.3 pp |
| 2019 | 92.7% | $119.83 Million | $129.22 Million | $129.28 Million | $9.45 Million | ▼ -44.7 pp |
| 2018 | 137.4% | $29.68 Million | $21.60 Million | $35.08 Million | $5.40 Million | ▲ +20.1 pp |
| 2017 | 117.3% | $68.85 Million | $58.71 Million | $79.53 Million | $10.68 Million | ▲ +79.3 pp |
| 2016 | 37.9% | $-6.34 Million | $-16.72 Million | $5.72 Million | $12.06 Million | ▲ +77.0 pp |
| 2015 | -39.1% | $1.71 Million | $-4.37 Million | $8.39 Million | $6.68 Million | — |